Stephanie Hsieh

Stephanie Hsieh currently serves as the Executive Director of Biocom California’s Los Angeles office, having earlier served on its Advisory Board. Biocom California is a $20 million, 1600 member, non-profit trade association for the life science industry. She is spearheading the transformation of the Greater Los Angeles Region into a premier life science hub.

Prior to joining Biocom California, Stephanie co-founded and grew Meditope Biosciences from academic technology concept to a preclinical stage oncology company. She created a successful patent portfolio strategy and raised $6.4 million in early-stage financing. Her career in biopharma spans 30 years, having held both corporate and law firm positions developing an expertise at the intersection of new product planning strategies and patent law and a reputation for building consensus by reframing issues and making complex information relatable.

In 2021, Stephanie was recognized by the LA Business Journal as one of the “most influential leaders and impactful executives in Los Angeles.” She graduated magna cum laude, Phi Beta Kappa, and Sigma Xi from Wellesley College, received a JD from Columbia Law School as a Harlan Fiske Stone Scholar, and holds an MBA from Stanford’s Graduate School of Business.